Search

Author/Creator Beher, Dirk

1. Current directions in tau research: Highlights from Tau 2020. Issue 5 (28th September 2021)

Authors:
Sexton, Claire; Snyder, Heather; Beher, Dirk; Boxer, Adam L.; Brannelly, Pat; Brion, Jean‐Pierre; Buée, Luc; Cacace, Angela M.; Chételat, Gaël; Citron, Martin; DeVos, Sarah L.; Diaz, Kristophe; Feldman, Howard H.; Frost, Bess; Goate, Alison M.; Gold, Michael; Hyman, Bradley; Johnson, Keith; Karch...
Journal:
Alzheimer's & dementia
Issue:
Volume 18:Issue 5(2022)
Page Start:
988
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Generation and characterization of a rabbit monoclonal antibody site‐specific for tau O‐GlcNAcylated at serine 400. Issue 22 (7th October 2013)

Authors:
Cameron, Andrew; Giacomozzi, Brandy; Joyce, John; Gray, Audrey; Graham, Danielle; Ousson, Solenne; Neny, Maud; Beher, Dirk; Carlson, George; O'Moore, Jill; Shearman, Mark; Hering, Heike
Journal:
FEBS letters
Issue:
Volume 587:Issue 22(2013)
Page Start:
3722
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. O1‐10‐01: PRECLINICAL PROFILES OF DRUG CANDIDATES PROMOTING O‐LINKED GLYCOSYLATION OF TAU FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND TAUOPATHIES. (1st July 2014)

Authors:
Quattropani, Anna; Beher, Dirk; Nény, Maud; Ousson, Solenne; Hantson, Jennifer; Sand, Astrid; Permanne, Bruno; Wiessner, Christoph
Journal:
Alzheimer's & dementia
Issue:
Volume 10:Supplement 4S(2014)Part 1
Page Start:
P148
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. O1‐12‐05: PHASE 1 STUDY IN HEALTHY VOLUNTEERS OF THE O‐GLCNACASE INHIBITOR ASN120290 AS A NOVEL THERAPY FOR PROGRESSIVE SUPRANUCLEAR PALSY AND RELATED TAUOPATHIES. (1st July 2006)

Authors:
Ryan, J. Michael; Quattropani, Anna; Abd-Elaziz, Khalid; den Daas, Izaak; Schneider, Manfred; Ousson, Solenne; Neny, Maud; Sand, Astrid; Hantson, Jennifer; Permanne, Bruno; Wiessner, Christoph; Beher, Dirk
Journal:
Alzheimer's & dementia
Issue:
Volume 14:Supplement 7S(2018)Part 4
Page Start:
P251
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. O3‐04‐04: Pharmacological intervention with the novel o‐glcnacase inhibitor ASN‐561 reduces pathological tau in transgenic mice. (1st July 2015)

Authors:
Permanne, Bruno; Quattropani, Anna; Hantson, Jennifer; Neny, Maud; Ousson, Solenne; Sand, Astrid; Wiessner, Christoph; Beher, Dirk
Journal:
Alzheimer's & dementia
Issue:
Volume 11(2015)Supplement 7:Part 5
Page Start:
P227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Substrate determinants in the C99 juxtamembrane domains differentially affect γ–secretase cleavage specificity and modulator pharmacology. (18th January 2013)

Authors:
Ousson, Solenne; Saric, Arman; Baguet, Aurelie; Losberger, Christophe; Genoud, Stephane; Vilbois, Francis; Permanne, Bruno; Hussain, Ishrut; Beher, Dirk
Journal:
Journal of neurochemistry
Issue:
Volume 125:Number 4(2013:May)
Page Start:
610
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗